News

The LitePoint IQxel-MX platform is leading the charge in the development and validation of next era, dependable, and ultra-high reliability Wi-Fi 8 applications SAN JOSE, Calif., September 16, ...
The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...
Researchers at the Cavendish Laboratory, University of Cambridge have demonstrated a new way to control radiation in the terahertz range—an often-overlooked part of the electromagnetic spectrum—with ...
This review discusses how nonlinear optics and intelligent control techniques are advancing ultrafast laser technology, enhancing performance and reliability.
Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study The interplay between the human ...
Credit: SetPoint Medical. The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve. In a phase 3 study, the SetPoint neuroimmune ...